České Budějovice

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Metastatic breast cancer1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• AstraZeneca2 trials

Running trials

• Active, not recruiting

  Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

  NCT00099437· Phase 3· AstraZeneca· Source

Closed trials

• Terminated

  Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

  NCT04847232· Phase 3· AstraZeneca· Source